Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Clinical trial NCT06732258 · WITHDRAWN

Trial details

NCT number: NCT06732258
Sponsor: Sichuan University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2025-01-10
Primary completion: 2026-02-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.